$BIIB Company News Is the next Cisco out there
Post# of 72749
Posted On: 12/01/2014 10:01:45 AM
$BIIB Company News
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog 5:00 p.m. Nov. 28, 2014 - Zacks.com
Prosensa Holding N.V. (RNA) Jumps: Stock Rises 8.6% - Tale of the Tape 8:51 a.m. Nov. 28, 2014 - Zacks.com
Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape 8:44 a.m. Nov. 28, 2014 - Zacks.com
How Much Is The Biotech Industry Stretched? 8:11 a.m. Nov. 28, 2014 - Seeking Alpha
Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog 11:50 a.m. Nov. 27, 2014 - Zacks.com
Best Idea For 2014: Sanofi Rights Post-FDA Approval 5:00 a.m. Nov. 27, 2014 - Seeking Alpha
Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog 5:10 p.m. Nov. 26, 2014 - Zacks.com
Isis Pharmaceuticals Earns Milestone on Study Initiation - Analyst Blog 5:00 p.m. Nov. 26, 2014 - Zacks.com
Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog 4:40 p.m. Nov. 26, 2014 - Zacks.com
Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog 10:54 a.m. Nov. 26, 2014 - Zacks.com
Mixed Readings For Biotech Short Interest 10:35 a.m. Nov. 26, 2014 - 247WallSt.com
Strength Seen in Kythera (KYTH): Stock Moves 5.5% Higher - Tale of the Tape 9:25 a.m. Nov. 26, 2014 - Zacks.com
Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog 6:56 p.m. Nov. 25, 2014 - Zacks.com
Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog 1:20 p.m. Nov. 25, 2014 - Zacks.com
FDA Orders New Label For Biogen Idec's MS Drug 1:05 p.m. Nov. 25, 2014 - benzinga.com
Tecfidera patient develops rare brain infection and dies 12:02 p.m. Nov. 25, 2014 - Seeking Alpha
Coronado Biosciences (CNDO) Jumps: Stock Rises 8.5% - Tale of the Tape 8:51 a.m. Nov. 25, 2014 - Zacks.com
Isis Pharma starts Phase 3 SMA trial 8:32 a.m. Nov. 25, 2014 - Seeking Alpha
Drug makers face pushback on pricey meds 8:18 a.m. Nov. 25, 2014 - Seeking Alpha
AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog 7:00 p.m. Nov. 24, 2014 - Zacks.com
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Today - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog 5:00 p.m. Nov. 28, 2014 - Zacks.com
Prosensa Holding N.V. (RNA) Jumps: Stock Rises 8.6% - Tale of the Tape 8:51 a.m. Nov. 28, 2014 - Zacks.com
Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape 8:44 a.m. Nov. 28, 2014 - Zacks.com
How Much Is The Biotech Industry Stretched? 8:11 a.m. Nov. 28, 2014 - Seeking Alpha
Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog 11:50 a.m. Nov. 27, 2014 - Zacks.com
Best Idea For 2014: Sanofi Rights Post-FDA Approval 5:00 a.m. Nov. 27, 2014 - Seeking Alpha
Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog 5:10 p.m. Nov. 26, 2014 - Zacks.com
Isis Pharmaceuticals Earns Milestone on Study Initiation - Analyst Blog 5:00 p.m. Nov. 26, 2014 - Zacks.com
Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog 4:40 p.m. Nov. 26, 2014 - Zacks.com
Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval - Analyst Blog 10:54 a.m. Nov. 26, 2014 - Zacks.com
Mixed Readings For Biotech Short Interest 10:35 a.m. Nov. 26, 2014 - 247WallSt.com
Strength Seen in Kythera (KYTH): Stock Moves 5.5% Higher - Tale of the Tape 9:25 a.m. Nov. 26, 2014 - Zacks.com
Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog 6:56 p.m. Nov. 25, 2014 - Zacks.com
Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog 1:20 p.m. Nov. 25, 2014 - Zacks.com
FDA Orders New Label For Biogen Idec's MS Drug 1:05 p.m. Nov. 25, 2014 - benzinga.com
Tecfidera patient develops rare brain infection and dies 12:02 p.m. Nov. 25, 2014 - Seeking Alpha
Coronado Biosciences (CNDO) Jumps: Stock Rises 8.5% - Tale of the Tape 8:51 a.m. Nov. 25, 2014 - Zacks.com
Isis Pharma starts Phase 3 SMA trial 8:32 a.m. Nov. 25, 2014 - Seeking Alpha
Drug makers face pushback on pricey meds 8:18 a.m. Nov. 25, 2014 - Seeking Alpha
AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog 7:00 p.m. Nov. 24, 2014 - Zacks.com
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Today - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
(0)
(0)